Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia
Withdrawn before enrolling · Phase 3
Conditions studied: Hyperglycemia, Leukemia
In brief
RATIONALE: Controlling blood sugar levels may be effective in preventing infections in patients receiving chemotherapy for acute myeloid leukemia or acute lymphoblastic leukemia. PURPOSE: This randomized phase I trial is studying how well controlling blood sugar levels works in preventing infection in patients with acute myeloid leukemia or acute lymphoblastic leukemia.
Key facts
- Study ID
- NCT00943709
- Run by
- University of Medicine and Dentistry of New Jersey
- People needed
- 0
- Starts
- 2009-05-01
- Expected to finish
- 2010-03-01
- Last updated by the study team
- 2013-08-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.